Healthy biotech M&A?

Discussing the impact of biotech deals on the sector overall, and whether Sanofi's offer for Medivation will pass, with Michael King, JMP Securities, and Les Funtleyder, E Squared Capital.

from Mergers and Acquisitions http://ift.tt/1SPQJXC